You have 9 free searches left this month | for more free features.

Carcinoma, Squamous Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with

Not yet recruiting
  • Advanced Esophageal Squamous Carcinoma With Oligometastases
  • simultaneous with radiotherapy
  • synchronous with radiotherapy
  • (no location specified)
Nov 16, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 30, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • no intervention
    • Wuhan, Hubei, China
      Renmin hosptial of Wuhan University
    Jul 29, 2023

    Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Head and Neck Squamous Cell Carcinoma
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 25, 2023

    Disease-free Survival of High-risk Head-neck Cutaneous Squamous

    Active, not recruiting
    • Carcinoma, Squamous Cell
    • +5 more
    • Treatment
    • Maastricht, Netherlands
    • +1 more
    Apr 26, 2023

    Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

    Not yet recruiting
    • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Oct 24, 2023

    Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

    Not yet recruiting
    • Squamous Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Jun 23, 2023

      Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Trial (Black Raspberry)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Oral Cavity or Oropharynx
      • Black Raspberry
      • (no location specified)
      Oct 16, 2023

      Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

      Recruiting
      • Oral Cancer
      • Oral Squamous Cell Carcinoma
      • ELISA
      • Fayoum, Egypt
        Fayoum University
      Sep 8, 2023

      Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

      Not yet recruiting
      • Esophageal Squamous Cell Carcinoma
      • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
      • (no location specified)
      Aug 17, 2023

      Tumors, Carcinoma, Squamous, Antineoplastic Agents Trial (Nivolumab Injection [Opdivo])

      Not yet recruiting
      • Neoplasms
      • +2 more
      • Nivolumab Injection [Opdivo]
      • (no location specified)
      Jul 19, 2023

      Oral Squamous Cell Carcinoma Trial (Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum

      Not yet recruiting
      • Oral Squamous Cell Carcinoma
      • Three-Week Treatment Regimen with Trastuzumab in Combination with Docetaxel and Platinum Triple Therapy
      • (no location specified)
      Nov 11, 2023

      Cutaneous Squamous Cell Carcinoma Trial (INCB099280)

      Not yet recruiting
      • Cutaneous Squamous Cell Carcinoma
      • (no location specified)
      May 24, 2023

      Head and Neck Squamous-cell Carcinoma

      Not yet recruiting
      • Squamous Cell Carcinoma of Head and Neck
      • +2 more
        • (no location specified)
        Nov 5, 2023

        Head and Neck Squamous Cell Carcinoma Trial (Carrilizumab, bevacizumab,capecitabine)

        Not yet recruiting
        • Head and Neck Squamous Cell Carcinoma
        • Carrilizumab, bevacizumab,capecitabine
        • (no location specified)
        Jul 20, 2023

        Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma

        Recruiting
        • Head and Neck Squamous Cell Carcinoma
          • Hangzhou, Zhejiang, China
            Second Affiliated Hospital, School of Medicine, Zhejiang Univers
          Aug 22, 2023

          Esophageal Squamous Cell Carcinoma Trial in Shanghai (Tirelizumab, Nab paclitaxel, Carboplatin)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • Shanghai, Shanghai, China
            Ruijin hospital, Shanghai jiaotong university school of medicine
          Nov 6, 2023

          Head and Neck Squamous Cell Carcinoma, Radiotherapy, Radiosensitizer Trial in China (Pirfenidone, Placebo)

          Recruiting
          • Head and Neck Squamous Cell Carcinoma
          • +3 more
          • Guangzhou, Guangdong, China
          • +4 more
          Nov 16, 2023

          Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)

          Not yet recruiting
          • Squamous Cell Carcinoma of the Skin
          • +2 more
          • Marlborough, Massachusetts
            Phio Pharmaceuticals Corp.
          Aug 25, 2023

          Advanced Lung Squamous Cell Carcinoma

          Not yet recruiting
          • Advanced Lung Squamous Cell Carcinoma
          • No treatment is included in this study
          • Changsha, Hunan, China
            Yongchang Zhang
          Aug 11, 2023

          Oral Squamous Cell Carcinoma, Oral Mucositis Trial in Guangzhou (Alfacalcidol Oral Solution, Placebo)

          Recruiting
          • Oral Squamous Cell Carcinoma
          • Oral Mucositis
          • Alfacalcidol Oral Solution
          • Placebo
          • Guangzhou, Guangdong, China
            Sun Yat-sen Memorial Hospital
          Aug 24, 2023

          Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy, Adjuvant Therapy Trial in Shanghai (Tislelizumab)

          Recruiting
          • Esophageal Squamous Cell Carcinoma
          • +2 more
          • Shanghai, Shanghai, China
            Shanghai chest hospital
          Sep 24, 2023

          Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

          Not yet recruiting
          • Head and Neck Squamous Cell Carcinoma
          • (no location specified)
          Aug 17, 2023